P206
Role of JAK inhibitors and immune cells in transplantation.
doi: 10.1016/j.cytogfr.2019.05.002
P205
Pharmaceuticals 2019, 12, 182;
A decade of antifungal leads from natural products: 2010-2019.
doi:10.3390/ph12040182.
P204
Med. Chem. Commun. 2019, 10, 1916-1925.
Evaluation of anti-inflammatory activity and molecular docking study of new aza-bicyclic isoxazoline acylhydrazone derivatives.
doi: 10.1039/c9md00276f
P203
Int. Immunopharmacol. 2019, 76, 105856.
Synthesis and pharmacological evaluation of CVIB, a codrug of carvacrol and ibuprofen as a novel anti-inflammatory agent.
doi:10.1016/j.intimp.2019.105856
P202
Pharmaceuticals 2019, 12, 169.
Biological evaluation of arylsemicarbazone derivatives as potential anticancer agents.
doi:10.3390/ph12040169
P201
Lipids Health Dis. 2019, 18, 168.
4-cholesten-3-one decreases breast cancer cell viability and alters membrane raft-localized EGFR expression by reducing lipogenesis and enhancing LXR-dependent cholesterol transporters.
doi: 10.1186/s12944-019-1103-7
P200
Bioorg. Med. Chem. 2019, 27, 3797-3804.
Thiazolidinedione and thiazole derivatives potentiate norfloxacin activity against NorA efflux pump over expression in Staphylococcus aureus 1199B strains.
doi: 10.1016/j.bmc.2019.07.006
P199
Curr. Top. Med. Chem. 2019, 19, 1075-1091.
5-Nitro-thiophene-thiosemicarbazone derivatives present antitumor activity mediated by apoptosis and DNA intercalation.
doi: 10.2174/1568026619666190621120304
P198
Cancers, 2019, 11, 1094.
Degradation of EGFR through the Allosteric Site Leads to Cancer Cell Detachment-Promoted Death.
doi: 10.3390/cancers11081094
P197
Mar. Drugs 2019, 17, 372.
Steroids from Marine-Derived Fungi: Evaluation of Antiproliferative and Antimicrobial Activities of Eburicol.
doi:10.3390/md17060372
P196
ChemBioChem 2019, 20, 2255-2261.
Rapid synthesis and antiproliferative properties of polyazamacrocycle-based bi- and tetra-gold(I) phosphine dithiocarbamate complexes.
doi: 10.1002/cbic.201900227
P195
La lettre de l’infectiologue. Editorial 2019 Tome XXXVI, 6, 234-235
Candida auris: should we fear the emergence of a highly resistant fungi?
P194
Hum. Immunol. 2019, 80, 999-1005.
Double positive CD4+CD8+ T cells are part of the adaptive immune response against Candida albicans.
doi: 10.1016/j.humimm.2019.09.008
P193
BMC Microbiol. 2019, 19, 106.
Comparison between MALDI-TOF MS and MicroScan in the identification of emerging and multidrug resistant yeasts in a fourth-level hospital in Bogotá, Colombia.
doi: 10.1186/s12866-019-1482-y
P192
J. Antimicrob. Chemother. 2019, 74, 2230-2238.
Precise genome editing using a CRISPR-Cas9 method highlights the role of CoERG11 amino acid substitutions in azole resistance in Candida orthopsilosis.
doi: 10.1093/jac/dkz204
P191
La Lettre de l'Infectiologue • Tome XXXIV - n° 3 - mai-juin 2019.
Brain abscess to Rasamsonia argillacea in a patient with chronic granulomatous disease.
P190
J. Cyst. Fibros. 2019, 18, 212-220.
Prevalence, geographic risk factor, and development of standardized protocol for fungal isolation in cystic fibrosis: results from the international prospective study "MFIP".
doi: 10.1016/j.jcf.2018.10.001
P189
J. Antimicrob. Chemother. 2019, 74, 1884-1889.
One-year prospective survey of azole resistance in Aspergillus fumigatus at a French cystic fibrosis reference centre: prevalence and mechanisms of resistance.
doi: 10.1093/jac/dkz144
P188
Int. J. Infect. Dis. 2019, 81, 85-90.
First case of Aspergillus caelatus airway colonization in a Chronic Obstructive Pulmonary Disease patient.
doi: 10.1016/j.ijid.2019.01.043
P187
Mycologia 2019, 111, 217-224.
Fungicide-driven alterations in azole-resistant Aspergillus fumigatus are related to vegetable crops in Colombia, South America.
doi: 10.1080/00275514.2018.1557796